Cargando…

Understanding the biology and use of TNF therapy in jia-clinical outcomes

Detalles Bibliográficos
Autores principales:	Lovell, Daniel, Johnson, Anne, Kimura, Yuki, Spalding, Steve, Morris, Paula, Gottlieb, Beth, Onel, Karen, Olson, Judyann, Edelheit, Barbara, Shisov, Michael, Jung, Lawrence, Cassidy, Elaine, Prahalad, Sampath, Passo, Murray, Beukelman, Tim, Mehta, Jay, Schmidt, Kara, Foell, Dirk, Hinze, Claas, Huang, Bin, Giannini, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190972/ http://dx.doi.org/10.1186/1546-0096-12-S1-P137

Ejemplares similares

Understanding the biology and use of anti-TNF agents in JIA – interim results
por: Lovell, Daniel J, et al.
Publicado: (2012)

High levels of DEK autoantibodies may predict early flare following cessation of anti-TNF therapy in juvenile idiopathic arthritis
por: Mor-Vaknin, Nirit, et al.
Publicado: (2014)

High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti–Tumor Necrosis Factor Therapy
por: Mor‐Vaknin, Nirit, et al.
Publicado: (2018)

Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline
por: Ganeva, Margarita, et al.
Publicado: (2021)

The effects of early aggressive therapy in JIA: results of the TREAT study
por: Wallace, Carol A, et al.
Publicado: (2012)

Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?
por: Cron, Randy Q, et al.
Publicado: (2010)

Temporomandibular joint arthritis in patients with non-JIA childhood arthritis
por: Cron, Randy Q, et al.
Publicado: (2012)

Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis
por: Angeles-Han, Sheila T., et al.
Publicado: (2015)

Development of consensus best treatment plans for new-onset systemic juvenile idiopathic arthritis
por: Morgan DeWitt, Esi M, et al.
Publicado: (2012)

4.4 Different phenotype of anaemia in systemic juvenile idiopathic arthritis (s-JIA) compared to anaemia in other subtypes of JIA
por: Hinze, CH, et al.
Publicado: (2008)

DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
por: Vojinovic, J, et al.
Publicado: (2008)

Disease characteristics and medication use in a multicenter cohort of children with juvenile idiopathic arthritis (JIA): preliminary analyses from the CARRAnet registry
por: Ringold, Sarah, et al.
Publicado: (2012)

Meta-analysis confirms association between TNFA-G238A variant and JIA, and between PTPN22-C1858T variant and oligoarticular, RF-polyarticular and RF-positive polyarticular JIA
por: Kaalla, Merlyn J, et al.
Publicado: (2013)

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
por: Pontikaki, I, et al.
Publicado: (2008)

PReS-FINAL-2002: Adverse events during anti-TNF therapy in patients with JIA
por: Tarkiainen, M, et al.
Publicado: (2013)

Epidemiology of JIA
por: Lahdenne, Pekka
Publicado: (2014)

The effects of TNF-alpha inhibitor therapy on the incidence of infection in JIA children: a meta-analysis
por: Nagy, Arnold, et al.
Publicado: (2019)

Prevalence of autoantibodies in patients with juvenile idiopathic arthritis: results from the German inception cohort ICON-JIA
por: Schulz, Caroline, et al.
Publicado: (2022)

Abatacept for severe anti-TNF-alfa refractory JIA-associated uveitis: one year follow-up
por: Alpigiani, MG, et al.
Publicado: (2011)

Munchausen by proxy syndrome mimicking systemic autoinflammatory disease: case report and review of the literature
por: Wittkowski, Helmut, et al.
Publicado: (2017)

JIA pathogenesis - genetics
por: Thomson, Wendy
Publicado: (2014)

Response to Jia and Wang
por: Liu, Xu, et al.
Publicado: (2020)

Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA)
por: Salmaso, A, et al.
Publicado: (2008)

MEFV mutations in systemic JIA
por: Aktay Ayaz, N, et al.
Publicado: (2008)

Mesenchymal stem cells and JIA
por: Swart, JF, et al.
Publicado: (2011)

eJIAS: Editor's Welcome
por: Wainberg, Mark A
Publicado: (2004)

The swedish paediatric JIA-registry
por: Magnusson, Bo
Publicado: (2014)

Monitoring local inflammation in JIA
por: Roth, Johannes
Publicado: (2014)

Puberty and disease activity in JIA
por: Van Pelt, Philomine, et al.
Publicado: (2014)

Clinical classification of JIA in Albania
por: Vula, Aurel, et al.
Publicado: (2014)

Progressive Pseudorheumatoid Dysplasia or JIA?
por: Wickrematilake, Geetha
Publicado: (2017)

Concordance between child and parent-proxy report on a new self-report tool of vision related quality of life for children with JIA-associated uveitis – “Effects of Youngsters’ Eyesight on QOL -EYE-Q”
por: Angeles-Han, Sheila T, et al.
Publicado: (2012)

Impact of a 2-yr anti-TNF treatment on the quality of life in JIA patients: a parent's/patient’s view
por: Diafa, K, et al.
Publicado: (2011)

A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)
por: Ramanan, Athimalaipet V., et al.
Publicado: (2018)

Profiling the peripheral immune response to ex vivo TNF stimulation in untreated juvenile idiopathic arthritis using single cell RNA sequencing
por: Imbach, Kathleen J., et al.
Publicado: (2023)

S100A12 as diagnostic tool in the differential diagnosis of sJIA associated MAS vs. hereditary or acquired HLH
por: Holzinger, D, et al.
Publicado: (2015)

Demographic, clinical and treatment characteristics of the carra registry systemic JIA cohort
por: Janow, Ginger, et al.
Publicado: (2014)

COVID-19 after rituximab therapy in cSLE patients
por: Nelson, Meghan Corrigan, et al.
Publicado: (2023)

Determing an “autoimmune” phenotype in systemic JIA
por: Fischer, N, et al.
Publicado: (2011)

Adverse events of methotrexate treatment in JIA
por: in ‘t Veld, J, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qdnt97ec2cf77tf3bob1ai8ddr